ZenenBio Withdraws Decision on 16 Billion KRW Third-Party Paid-in Capital Increase

ZenenBio announced on the 13th that it has withdrawn the decision for a third-party allotment paid-in capital increase worth 16 billion KRW.

ZenenBio had announced on July 26 of last year that it would conduct a paid-in capital increase of 28.58 million shares targeting JYC Co., Ltd. to raise operating funds and debt repayment funds.

The company explained the reason for the withdrawal as "non-payment by the third-party allottee, JYC Co., Ltd."